ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Clinical trials for ANN ARBOR STAGE IIA HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new ANN ARBOR STAGE IIA HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for ANN ARBOR STAGE IIA HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for seniors with hodgkin lymphoma: Chemo-Free combo shows promise
Disease control OngoingThis study tests a combination of two drugs, nivolumab and brentuximab vedotin, in people aged 60 or older (or younger people who cannot handle standard chemo) with untreated Hodgkin lymphoma. The goal is to see if this drug pair can shrink or eliminate the cancer without the har…
Matched conditions: ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 17, 2026 13:55 UTC
-
Smart scan guides lymphoma therapy, spares unneeded drugs
Disease control OngoingThis study tests a personalized approach for people with early-stage Hodgkin lymphoma (stages I-II). Doctors use PET scans to see how well the cancer responds to initial chemotherapy, then adjust the treatment plan—adding or skipping certain drugs—to improve outcomes and reduce s…
Matched conditions: ANN ARBOR STAGE IIA HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Academic and Community Cancer Research United • Aim: Disease control
Last updated May 07, 2026 18:43 UTC